Federica Cherchi

Florence, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Protective effects of adenosine A2B receptor antagonism in a cuprizone-induced demyelination model.

Protective effects of adenosine A2B receptor antagonism in a cuprizone-induced demyelination model.

Journal: Neuropharmacology
Published: January 08, 2026

Human Foetal Neuroblasts Exhibit BK Channel-Dependent Membrane Voltage Oscillations upon Depolarization.

Human Foetal Neuroblasts Exhibit BK Channel-Dependent Membrane Voltage Oscillations upon Depolarization.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 31, 2025

Adenosine A2A receptor blockade promotes oligodendrocyte differentiation and myelination: Highlighting the potency of an edaravone-conjugated A2A receptor antagonist.

Adenosine A2A receptor blockade promotes oligodendrocyte differentiation and myelination: Highlighting the potency of an edaravone-conjugated A2A receptor antagonist.

Journal: Neuropharmacology
Published: July 08, 2025

8-Amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives hybridized with antioxidants: new highly potent and selective human A2A adenosine receptor antagonists as useful agents against cerebral ischemia.

8-Amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives hybridized with antioxidants: new highly potent and selective human A2A adenosine receptor antagonists as useful agents against cerebral ischemia.

Journal: Bioorganic chemistry
Published: June 18, 2025

Protection From Demyelination by the Novel Adenosine Dual A2A/A2B Receptor Antagonist P626 in EAE and Cultured Oligodendrocyte Precursor Cells.

Protection From Demyelination by the Novel Adenosine Dual A2A/A2B Receptor Antagonist P626 in EAE and Cultured Oligodendrocyte Precursor Cells.

Journal: Journal of cellular and molecular medicine
Published: April 13, 2025

A new approach to psoriasis therapy: photoswitchable A3 adenosine receptor activation.

A new approach to psoriasis therapy: photoswitchable A3 adenosine receptor activation.

Journal: Purinergic signalling
Published: February 05, 2025

Editorial: Role of ion channels and metabotropic receptors in oligodendrogliogenesis: novel targets for demyelinating pathologies.

Editorial: Role of ion channels and metabotropic receptors in oligodendrogliogenesis: novel targets for demyelinating pathologies.

Journal: Frontiers in cellular neuroscience
Published: October 25, 2024

Natural aminosterols inhibit NMDA receptors with low nanomolar potency.

Natural aminosterols inhibit NMDA receptors with low nanomolar potency.

Journal: The FEBS journal
Published: August 23, 2024

MRS3997, a dual adenosine A2A/A2B receptor agonist, reduces brain ischemic damage and alleviates neuroinflammation in rats.

MRS3997, a dual adenosine A2A/A2B receptor agonist, reduces brain ischemic damage and alleviates neuroinflammation in rats.

Journal: Neuropharmacology
Published: May 28, 2024

Adenosine A2B receptors differently modulate oligodendrogliogenesis and myelination depending on their cellular localization.

Adenosine A2B receptors differently modulate oligodendrogliogenesis and myelination depending on their cellular localization.

Journal: Glia
Published: November 08, 2023

Adenosine A2A receptor blockade attenuates excitotoxicity in rat striatal medium spiny neurons during an ischemic-like insult.

Adenosine A2A receptor blockade attenuates excitotoxicity in rat striatal medium spiny neurons during an ischemic-like insult.

Journal: Neural regeneration research
Published: July 25, 2023

Adenosine Receptors as Potential Therapeutic Analgesic Targets.

Adenosine Receptors as Potential Therapeutic Analgesic Targets.

Journal: International journal of molecular sciences
Published: June 24, 2023
Showing 1-12 of 34

Last Updated: 09/26/2026